These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8282580)

  • 1. [Cerebral seizure in naftidrofuryl infusion].
    Maier W; Löhle E
    HNO; 1993 Nov; 41(11):539-41. PubMed ID: 8282580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sudden deafness--on the age dependence of therapy results with reference to naftidrofuryl (Dusodril)].
    Koehn W; Nickol HJ
    HNO; 1985 Jan; 33(1):36-9. PubMed ID: 3972647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Randomized double-blind study of therapy of sudden deafness. Low molecular weight dextran + naftidrofuryl vs. low molecular weight dextran + placebo].
    Poser R; Hirche H
    HNO; 1992 Oct; 40(10):396-9. PubMed ID: 1385372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical aspects and therapy of sudden deafness. Data of a patient sample of the ear, nose, throat clinic of the Wiesbaden City Clinic 1974-1982].
    Zastrow G; Arndt HJ
    Laryngol Rhinol Otol (Stuttg); 1987 May; 66(5):237-41. PubMed ID: 3613774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of sudden deafness--naftidrofuryl (Dusodril) and pentoxifylline (Trental) compared].
    Laskawi R; Schrader B; Schröder M; Poser R; von der Brelie R
    Laryngol Rhinol Otol (Stuttg); 1987 May; 66(5):242-5. PubMed ID: 3302568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospective randomized study on the comparative effect between 10% HES 200/0.5 and 6% HES 200/0.5 in patients with hearing loss].
    Friedrich G; Ott E
    Laryngorhinootologie; 1991 Dec; 70(12):670-4. PubMed ID: 1721814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of sudden deafness with the calcium antagonist nimodipine. Results of a comparative study].
    Lenarz T
    Laryngorhinootologie; 1989 Nov; 68(11):634-7. PubMed ID: 2690838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ginkgo extract EGb 761 (tenobin)/HAES versus naftidrofuryl (Dusodril)/HAES. A randomized study of therapy of sudden deafness].
    Hoffmann F; Beck C; Schutz A; Offermann P
    Laryngorhinootologie; 1994 Mar; 73(3):149-52. PubMed ID: 7513516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Status epilepticus and transient disorders of heart conduction induced by too fast intravenous infusion of naftidrofuryl].
    Rey JL; Quiret JC; Gamain J; Errasti M
    Nouv Presse Med; 1978 May; 7(21):1864. PubMed ID: 673747
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential nephrotoxicity of intravenous infusions of naftidrofuryl oxalate.
    Le Meur Y; Moesch C; Rincé M; Aldigier JC; Leroux-Robert C
    Nephrol Dial Transplant; 1995; 10(9):1751-5. PubMed ID: 8559500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Convulsive crises and cardiovascular complications following high-dosage parenteral administration of naftidrofuryl].
    Pohlmann-Eden B; Linden D; Bergler W
    Dtsch Med Wochenschr; 1991 Sep; 116(38):1453. PubMed ID: 1893861
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prognostic criteria in sudden deafness].
    Linssen O; Schultz-Coulon HJ
    HNO; 1997 Jan; 45(1):22-9. PubMed ID: 9132396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Slow ventricular tachycardia caused by naftidrofuryl overdose (naftidrofuryl and ventricular tachycardia)].
    Malaterre HR; Ferracci A; Ebagosti A; Faugier JP; Charles D; Levy S
    Ann Cardiol Angeiol (Paris); 1992 Sep; 41(7):379-81. PubMed ID: 1285624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Allergic reaction in therapy with naftidrofuryl (Dusodril). A case report].
    Matschke RG
    HNO; 1987 May; 35(5):219-21. PubMed ID: 3610682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion disorder in a child presenting as sudden sensorineural hearing loss.
    Rotenberg BW; Makhija M; Papsin BC
    Int J Pediatr Otorhinolaryngol; 2005 Sep; 69(9):1261-4. PubMed ID: 15964081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Randomized double-blind study of therapy of sudden deafness: initial results].
    Desloovere C; Meyer-Breiting E; von Ilberg C
    HNO; 1988 Oct; 36(10):417-22. PubMed ID: 2466024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular complications due to naftidrofuryl].
    Ducloux G; Marchand X; Laurent JM; Lecoutour X; Puech F; Delecour M
    Ann Cardiol Angeiol (Paris); 1985 Mar; 34(3):167-9. PubMed ID: 3923893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of sudden deafness].
    Schätzle W; Wilhelm HJ; Federspil P
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1981 Oct; 30(8):495-9. PubMed ID: 6170722
    [No Abstract]   [Full Text] [Related]  

  • 19. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy.
    Plaza G; Herráiz C
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):74-8. PubMed ID: 17599569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute renal failure due to naftidrofuryl oxalate Praxilène overdose in a kidney transplant recipient.
    Cuvelier C; Goffin E; Cosyns JP; Claeys N; Squifflet JP; Pirson Y; de Strihou CV
    Nephrol Dial Transplant; 1995; 10(9):1756-8. PubMed ID: 8559501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.